Indegene IPO GMP Today in the Grey Market is Not Available at The Moment. Investors are Advised to Closely Monitor Market Trends and consult Reliable Sources for the Most up-to-date Information. It is important to Exercise Caution and Conduct Thorough Research Before Making any Investment Decisions.
About Indegene IPO-
How Much GMP Price Indegene IPO today?, live Grey Market Premium Kostak Rates today live Indegene IPO Now. Subject to sauda Rate today, Indegene IPO as of today Subject to sauda rates kostak.
Indegene IPO is to open on May 6, 2024. Indegene is a BSE & NSE IPO to raise [.] Shares (Approx ₹ [.] Cr) Via IPO. The Indegene IPO Price Band is Fixed At ₹70 Per Every Share With a IPO Lot Size of [.] Shares.
About Indegene Data Like –
- Manish Gupta is the CEO of Indegene and Indegene was founded in the year 1998 and has just completed 24 years in operation.
- Indegene is A “Digital-First” Commercialization Company Focused Exclusively On The Global Life Sciences Industry. Our Solutions Enable Biopharmaceutical, Emerging Biotech And Medical Devices Companies Develop Products, Launch Them In The Market, And Drive Sales Through Their Life Cycle In A More Effective, Efficient And Modern Manner.
- We Achieve This By Combining Over Two Decades Of Healthcare Domain Expertise And Fit-For-Purpose Technology. Our Portfolio Of Solutions Cover All Aspects Of Commercial, Medical, Regulatory And R&D Operations Of Life Sciences Companies.
What is Indegene IPO GMP Today?
The Indegene IPO GMP Today is ₹266.
What is Indegene IPO Sauda Price Today?
The Indegene IPO Sauda price Today is ₹6700/93,800.
Indegene IPO GMP With Per Lot Profit
| DATE | IPO GMP PRICE | EST LISTING PRICE |
|---|---|---|
| 13 May | ₹302 | ₹754 |
| 12 May | ₹302 | ₹754 |
| 11 May | ₹302 | ₹754 |
| 10 May | ₹280 | ₹732 |
| 9 May | ₹264 | ₹716 |
| 8 May | ₹249 | ₹701 |
| 7 May | ₹255 | ₹707 |
| 6 May | ₹264 | ₹716 |
| 5 May | ₹264 | ₹716 |
| 4 May | ₹266 | ₹718 |
| 3 May | ₹247 | ₹699 |
| 2 May | ₹240 | ₹692 |
| 1 May | ₹225 | ₹677 |
| 30 April | ₹170 | ₹622 |
| 29 April | ₹170 | ₹622 |
| 28 April | ₹170 | ₹622 |
| 28 April | ₹170 | ₹622 |
| 27 April | ₹160 | ₹612 |
Also Read : Indegene IPO Details Today, GMP Price, Date, Review
Latest IPO GMP
We Update live GMP status of all upcoming IPOs every day until the IPO gets listed on the stock exchange. You can easily see the GMP price of all IPOs on our IPO GMP dashboard. We update IPO GMP performance regularly on Moneymintidea.com. You can easily get a rough idea of the GMP of all IPOs and what the listing price of the IPO is going to be.
IPO Grey Market Premium (GMP)
Before investing money in any IPO, one should pay more attention to the fact that the IPO GMP price is very volatile, if you are thinking of investing in Indegene IPO by looking at the GMP price, then your decision may prove to be quite risky. Before investing in a new IPO, you should have good knowledge about the business of the company. It should be your decision whether to invest in Indegene IPO or not and not by looking at the GMP price of the IPO.
Grey Market Premium (GMP) is the price at which an IPO is traded in an informal/unregulated manner before getting listed on the stock exchange. GMP price in the gray market reflects the price at which a company’s IPO is listed. Going to do. A good GMP premium/price gives you an indication of how much profit the IPO will make upon listing. Rather, if the GMP premium of an IPO is negative, then one should avoid investing money in that IPO.
Disclaimer:- The article here should not be construed as an offer to you to buy or sell based on any IPO / Gray Market Premium (GMP) or as advice in any way. The article here is written for informational and educational informational purposes only. This article should not be relied upon for investing in IPOs. Readers should consult a qualified financial advisor before making investment decisions.
Any reader making any investment decision based on the information published here does so entirely at his own risk. Investors should be aware that any investment in the equity market is subject to unpredictable market-related risks. The author does not intend to invest in this offering.
